News
22 November, 2024
Recommendation of the President – Abrysvo (respiratory syncytial virus vaccine bivalent, recombinant)
more...22 November, 2024
Recommendation of the President – Abrysvo (respiratory syncytial virus vaccine bivalent, recombinant)
more...21 November, 2024
Communication of the meeting of Transparency Council No. 48/2024 on 18 November 2024
more...19 November, 2024
Communication of the meeting of Transparency Council No. 47/2024 on 12 November 2024
more...15 November, 2024
Position of the Transparency Council – Abrysvo respiratory syncytial virus vaccine (bivalent, recombinant)
more...15 November, 2024
Position of the Transparency Council – Abrysvo respiratory syncytial virus vaccine (bivalent, recombinant)
more...08 November, 2024